No, but gene editing technology will continue to develop.

The world's first gene-edited baby was born in China in November, and the ethics surrounding the birth have been the focus rather than the technology itself. That means there will be heightened supervision, so similar clinical trials are unlikely to happen this year.

It does not mean that the technology will cease development. Experts in clustered regularly interspaced short palindromic repeats, or CRISPR, gene editing will try their hardest to avoid ethical issues and focus on somatic cells that do not pass genetic information onto the next generation. There will still be advances, and humans must make a choice that could influence the future of the entire species.